CVT
01/04/2016 15:16
DIRECTOR
NOT PRICE SENSITIVE
REL: 1516 HRS Comvita Limited
DIRECTOR: CVT: Comvita appoints new Independent Director
The Board of natural health products company, Comvita is pleased to announce
the appointment of Murray Denyer as an Independent Director of Comvita,
effective from 01 April 2016.
Murray is an experienced commercial lawyer having advised and worked with
both large and medium sized New Zealand companies, State Owned Enterprises,
and government departments. As a former New Zealand diplomat and government
international trade lawyer, he also has specialist expertise in international
trade law and policy.
Murray spent five years as General Counsel and Board Secretary with Zespri
International Limited, and is now a Partner at the law firm Cooney Lees
Morgan in Tauranga which he joined in 2009. His legal practice spans company
and commercial law, mergers and acquisitions, agribusiness and international
trade law and policy. Murray's strong background in these disciplines plus
his extensive knowledge in human resources and remuneration matters, will be
complementary to the skills of the existing Board Members. Murray was also
on the Board of Priority One, the business development agency in Tauranga,
for eight years with the last three being Chair, and is a Director of
Enterprise Angels, the local BOP/Waikato angel investment group.
In accordance with the Comvita Constitution, Murray will be formally
nominated for re-election to the Board at the 2016 annual meeting in October.
If elected, it is anticipated Murray will assume the role of Chair of the
Remuneration & HR Committee of the Board of Comvita, from Dr David Cullwick
who retires from the Board in October this year.
Ends
For further information:
Scott Coulter, Comvita CEO, 021 386 988
Neil Craig, Comvita Chairman, 021 731 509
Julie Chadwick, Comvita Communications Manager, 021 510 693
Background information
About Comvita (www.comvita.com)
Comvita (NZX:CVT) is a global natural health company committed to the
development of innovative products, backed by ongoing investment in
scientific research.
End CA:00280221 For:CVT Type:DIRECTOR Time:2016-04-01 15:16:37
